5526 - 5550 of 8399 Results
Title
Year
- Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice2019OPENTitle: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient miceJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 4Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci.insight.126769Best OA location URL: https://doi.org/10.1172/jci.insight.126769Citation Count: 19
-
OPENTitle: Hiding in Plain Sight: Functional Neurological Disorders in the NewsJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 31Issue #: 4Start Page: 361End Page: 367Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.19010025Best OA location URL: https://neuro.psychiatryonline.org/doi/pdf/10.1176/appi.neuropsych.19010025Citation Count: 18
- One Step Into the Future: New iPSC Tools to Advance Research in Parkinson’s Disease and Neurological Disorders2019RESTRICTEDTitle: One Step Into the Future: New iPSC Tools to Advance Research in Parkinson’s Disease and Neurological DisordersJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 9Issue #: 2Start Page: 265End Page: 281Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181515Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181515?id=journal-of-parkinsons-disease%2Fjpd181515Citation Count: 20
-
RESTRICTEDTitle: Gait and postural disorders in parkinsonism: a clinical approachJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 11Start Page: 3169End Page: 3176Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09382-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09382-1.pdfCitation Count: 32
- Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset2019OPENTitle: Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onsetJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0080-xBest OA location URL: https://www.nature.com/articles/s41531-019-0080-x.pdfCitation Count: 124
-
OPENTitle: The neuro-toxin MPTP does not prevent reproduction in marmosetsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.12688/mniopenres.12818.2Best OA location URL: https://mniopenresearch.org/articles/3-2/v2/pdfCitation Count: 0
- Non-canonical function of IRE1α determines mitochondria-associated endoplasmic reticulum composition to control calcium transfer and bioenergetics2019OPENTitle: Non-canonical function of IRE1α determines mitochondria-associated endoplasmic reticulum composition to control calcium transfer and bioenergeticsJournal Name: Nature Cell BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 6Start Page: 755End Page: 767Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41556-019-0329-yBest OA location URL: https://europepmc.org/articles/pmc7246037?pdf=renderCitation Count: 194
-
OPENTitle: Parkinson's disease motor subtype changes during 20 years of follow-upJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 104End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.024Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980332Citation Count: 27
- Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease2019RESTRICTEDTitle: Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 126Issue #: 6Start Page: 789End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-019-02015-xCitation Count: 3
- GenePy - a score for estimating gene pathogenicity in individuals using next-generation sequencing data2019OPENTitle: GenePy - a score for estimating gene pathogenicity in individuals using next-generation sequencing dataJournal Name: BMC BioinformaticsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12859-019-2877-3Best OA location URL: https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/s12859-019-2877-3Citation Count: 31
- Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease2019OPENTitle: Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 402Issue #:Start Page: 81End Page: 85Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.009Best OA location URL: https://zenodo.org/records/3873416/files/Proof_from_JNS-D-19-00244R1.pdfCitation Count: 6
- Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on Aging2019OPENTitle: Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on AgingJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 42Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsz114Best OA location URL: https://academic.oup.com/sleep/article-pdf/42/8/zsz114/29106505/zsz114.pdfCitation Count: 58
- Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils2019OPENTitle: Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 129Issue #:Start Page: 67End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2019.05.012Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749993Citation Count: 63
- L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression2019OPENTitle: L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.022Best OA location URL: https://eprints.gla.ac.uk/191364/1/191364.pdfCitation Count: 24
-
RESTRICTEDTitle: Clinical phenotype in carriers of intermediate alleles in the huntingtin geneJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 402Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.010Citation Count: 27
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint2019OPENTitle: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpointJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 11End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012Best OA location URL: https://doi.org/10.1016/j.jalz.2019.01.012Citation Count: 40
-
OPENTitle: Clinical implications of early caudate dysfunction in Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 10Start Page: 1098End Page: 1104Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2018-320157Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/10/1098.full.pdfCitation Count: 69
-
OPENTitle: Early‐onset pathologically proven multiple system atrophy with LRRK2 G2019S mutationJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 7Start Page: 1080End Page: 1082Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27710Best OA location URL: https://europepmc.org/articles/pmc6642007?pdf=renderCitation Count: 26
- Identifying and ranking potential driver genes of Alzheimer’s disease using multiview evidence aggregation2019OPENTitle: Identifying and ranking potential driver genes of Alzheimer’s disease using multiview evidence aggregationJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 35Issue #: 14Start Page: i568End Page: i576Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/bioinformatics/btz365Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/35/14/i568/28913444/btz365.pdfCitation Count: 14
- Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding2019OPENTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 35Issue #:Start Page: 42End Page: 47.e1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074509Citation Count: 11
-
OPENTitle: Regional neuropathology distribution and verbal fluency impairments in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.014Best OA location URL: http://manuscript.elsevier.com/S1353802019302354/pdf/S1353802019302354.pdfCitation Count: 20
- Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease2019OPENTitle: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s diseaseJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 9Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025Best OA location URL: https://doi.org/10.1016/j.cophys.2019.04.025Citation Count: 9
- Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort2019OPENTitle: Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohortJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 266Issue #: 8Start Page: 1927End Page: 1936Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09348-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09348-3.pdfCitation Count: 160
- The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss2019OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592621Citation Count: 11
-
OPENTitle: TREM2 brain transcript-specific studies in AD and TREM2 mutation carriersJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-019-0319-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-019-0319-3Citation Count: 82